Global In Vitro Fertilization Market

Global In Vitro Fertilization Market Size, Share, Growth Analysis, By Product Type(Fresh Donor, Fresh Non-Donor), By End-use(Fertility Clinics, Surgical Centers) - Industry Forecast 2024-2031

Report ID: SQMIG35H2163 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 65 | Figures: 75

Global In Vitro Fertilization Market News

  • June of 2023 The debut of MilliporeSigma's new CellToxTM Assay Platform was announced. The platform consists of a collection of in vitro tests intended to evaluate the safety of substances and medications.

  • WuXi AppTec announced in May 2023 that its in vitro toxicological capabilities have expanded. New assays will be included as part of the expansion, and a new service for creating personalized in vitro assays will be introduced.

  • Thermo Fisher Scientific Inc. said in April 2023 that it had acquired CooperSurgical, an IVF supplier of goods and services. Thermo Fisher will be able to increase its market share in the IVF sector thanks to the acquisition.

  • Vitrolife declared in March 2023 that the FDA has approved its Cryotop vitrification device. A novel method for vitrifying embryos—a quick freezing procedure used to maintain their viability—is the Cryotop system.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global In Vitro Fertilization Market size was valued at USD 23.75 Billion in 2022 and is poised to grow from USD 25.10 Billion in 2023 to USD 39.11 Billion by 2031, at a CAGR of 5.7% during the forecast period (2024-2031).

The global In vitro fertilization market is characterized by the presence of several key players, including fertility clinics, medical device manufacturers, pharmaceutical companies, and genetic testing laboratories. These companies compete based on factors such as product offerings, technology advancements, success rates, pricing, and geographical presence. Here is an elaboration on the competitive landscape of the IVF market. Companies in the IVF market also engage in strategic initiatives such as mergers and acquisitions, partnerships, and collaborations to expand their product portfolios, enhance their geographic presence, and strengthen their research and development capabilities. They also invest in technological advancements, such as time-lapse imaging systems, embryo selection algorithms, and cryopreservation techniques, to improve success rates and patient experience. 'CooperSurgical, Inc. (US)', 'Vitrolife AB (Sweden)', 'Cook Medical (US)', 'Irvine Scientific (US)', 'Merck KGaA (Germany)', 'Thermo Fisher Scientific, Inc. (US)', 'Esco Micro Pte Ltd (Singapore)', 'Genea Limited (Australia)', 'Ferring Pharmaceuticals (Switzerland)', 'Hamilton Thorne, Inc. (Canada)', 'Nidacon International AB (Sweden)', 'Rocket Medical plc (UK)', 'EMD Serono (US)', 'OvaScience (US)', 'Kitazato Corporation (Japan)', 'IVFtech Aps (Denmark)', 'Zeiss Group (Germany)', 'Igenomix (Spain)', 'Labotect GmbH (Germany)', 'Esco Medical (Singapore)'

In 2021, there were significant advancements in reproductive technologies used in IVF procedures. For instance, the introduction of time-lapse imaging systems allowed continuous monitoring of embryo development, leading to improved selection and higher success rates. These advancements attracted more individuals and couples to undergo IVF treatments.

Rising Demand for Genetic Testing: In 2022, there was a growing trend towards the use of genetic testing techniques, such as preimplantation genetic testing (PGT), in IVF procedures. PGT allows the screening of embryos for genetic abnormalities before implantation, increasing the chances of successful pregnancies and reducing the risk of genetic disorders in offspring.

In 2022, Asia Pacific region is expected to witness a remarkable compound annual growth rate (CAGR) during the forecast period in the in-vitro fertilization (IVF) market. This growth can be attributed to several factors, including the large population base, rapidly declining fertility rates, increasing government initiatives focused on women, a growing preference for careers over starting a family among women, and increased awareness regarding fertility clinics and procedures. The region benefits from growing awareness of IVF, rising healthcare expenditure, and increased adoption of advanced reproductive technology. Additionally, the rise of medical tourism in the region is expected to impact the growth of the IVF market. countries like Japan and South Korea are facing declining population rates due to the increasing median age of first-time mothers. Women in these countries prioritize their careers and tend to delay starting a family during their 20s. This trend results in delayed marriages and pregnancies. Women over the age of 35 have a higher risk of miscarriage and stillbirth, which can lower the success rate of fertility treatments.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global In Vitro Fertilization Market

Report ID: SQMIG35H2203 | Region: Global | Published Date: March, 2024 | Pages: 157 | Tables: 66 | Figures: 75

Global Laboratory Mixer Market
Buy Now GET FREE SAMPLE
Global In Vitro Fertilization Market

Report ID: UCMIG35H2147 | Region: Global | Published Date: March, 2024 | Pages: 165 | Tables: Figures:

miRNA Sequencing And Assay Market
Buy Now GET FREE SAMPLE
Global In Vitro Fertilization Market

Report ID: SQMIG35H2230 | Region: Global | Published Date: March, 2024 | Pages: 157 | Tables: 62 | Figures: 75

Global Hemoglobinopathies Treatment Market
Buy Now GET FREE SAMPLE
Global In Vitro Fertilization Market

Report ID: SQMIG35H2164 | Region: Global | Published Date: March, 2024 | Pages: 219 | Tables: 64 | Figures: 75

Global Metabolomics Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global In Vitro Fertilization Market

Product ID: SQMIG35H2163

$5,300
BUY NOW GET FREE SAMPLE